Literature DB >> 33231614

Efficacy of Intralesional Platelet-Rich Plasma in Diabetic Foot Ulcer.

Ajay Gupta, Chethan Channaveera, Satyaranjan Sethi, Sunil Ranga, Vijender Anand.   

Abstract

BACKGROUND: Diabetic foot ulcer (DFU) is well managed by infection control, euglycemic state, and debridement of the ulcer followed by appropriate dressing and off-loading of the foot. Studies show that approximately 90% of DFUs that are properly off-loaded heal in nearly 6 weeks. Platelet-rich plasma (PRP) serves as a growth factor agonist and has mitogenic and chemotactic properties that help in DFU healing. We sought to evaluate the efficacy of local application of PRP with respect to healing rate and ulcer area reduction in treating DFUs.
METHODS: Sixty noninfected patients with DFUs (plantar surface area, ≤20 cm2; Meggitt-Wagner grades 1 and 2) were randomized to receive normal saline dressing (control group [CG]) or PRP dressing (study group [SG]) along with total-contact casting for 6 weeks or until complete ulcer healing, whichever was earlier. Healing rate and change in ulcer area were evaluated weekly.
RESULTS: Mean ± SD ulcer area at baseline was 4.96 ± 2.89 cm2 (CG) and 5.22 ± 3.82 cm2 (SG) (P = .77), decreasing to 1.15 ± 1.35 cm2 (CG) and 0.96 ± 1.53 cm2 (SG) (P = .432) at 6 weeks. Mean ± SD percentage reduction in healing area at 6 weeks was 81.72% ± 17.2% (CG) and 85.98% ± 13.42% (SG) (P = .29). Mean ± SD healing rate at 6 weeks was 0.64 ± 0.36 cm2 (CG) and 0.71 ± 0.46 cm2 (SG) (P = .734).
CONCLUSIONS: The PRP dressing is no more efficacious than normal saline dressing in the management of DFU in conjunction with total-contact casting.

Entities:  

Year:  2021        PMID: 33231614     DOI: 10.7547/19-149

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  2 in total

1.  A Simple Double-Spin Closed Method for Preparing Platelet-Rich Plasma.

Authors:  Edilson S Machado; Fabiano P Soares; Roberta S Yamaguchi; William K Felipone; Robert Meves; Tais Amara C Souza; Roberto Topolniak; José P Caldas; Ernani V Abreu; Luiz S Rabelo Neto; Pedro Vinicius S Pinchemel; Markus Bredemeier
Journal:  Cureus       Date:  2022-01-03

2.  Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers.

Authors:  Andreas Kerstan; Kathrin Dieter; Elke Niebergall-Roth; Markus H Frank; Mark A Kluth; Sabrina Klingele; Michael Jünger; Christoph Hasslacher; Georg Daeschlein; Lutz Stemler; Ulrich Meyer-Pannwitt; Kristin Schubert; Gerhard Klausmann; Titus Raab; Matthias Goebeler; Korinna Kraft; Jasmina Esterlechner; Hannes M Schröder; Samar Sadeghi; Seda Ballikaya; Martin Gasser; Ana M Waaga-Gasser; George F Murphy; Dennis P Orgill; Natasha Y Frank; Christoph Ganss; Karin Scharffetter-Kochanek
Journal:  Stem Cell Res Ther       Date:  2022-09-05       Impact factor: 8.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.